Beam Therapeutics BEAM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$414.64M— | -$398.58M— | -$386.4M— | ||
| $22.37M+1.6% | $22.29M+1.7% | $22.07M+1.0% | $21.98M+2.0% | $22.02M+5.9% | ||
| $86.61M-26.6% | $94.24M-21.9% | $104.01M-8.0% | $110.83M+1.4% | $118.06M+13.5% | ||
| -$369.73M-5.2% | -$345.1M+0.6% | -$338.18M— | -$344.82M— | -$351.38M— | ||
| $14.11M+47.4% | $14.95M+67.1% | $14.18M+48.3% | $10.75M-32.6% | $9.57M-68.3% | ||
| —— | —— | —— | -$144.52M-219% | $113.38M+1,703% | ||
| —— | —— | —— | —— | —— | ||
| $101.28M-78.8% | $478.05M+6,080% | $479.61M+1,162% | $479.19M+552% | $478.22M+164% | ||
| -$239.53M— | $11.51M— | —— | —— | —— | ||
| -$383.84M-6.3% | -$360.05M-1.1% | -$352.36M— | -$355.57M— | -$360.96M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Beam Therapeutics generate?
- Beam Therapeutics (BEAM) generated -$369.7M in operating cash flow over the trailing twelve months.
- What is Beam Therapeutics's free cash flow?
- After $14.1M of capital expenditures, Beam Therapeutics's free cash flow was -$383.8M over the trailing twelve months, down 6.3% year over year.
- Where does Beam Therapeutics's cash flow data come from?
- Every line is extracted from Beam Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
